About the Luxembourg Centre for Systems Biomedicine


The Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg  is accelerating biomedical research by closing the link between systems biology and medical research. Collaboration between biologists, medical doctors, computer scientists, physicists, engineers and mathematicians is offering new insights in complex systems like cells, organs, and organisms. These insights are essential for understanding principal mechanisms of disease pathogenesis and for developing new tools in diagnostics and therapy.

The LCSB combines experimental and computational approaches to analyse complex biological systems and disease processes with a strong focus on neuropathology including neurodegeneration and epilepsy. The overarching strategy of the interdisciplinary research centre is to combine systematically experimental and theoretical approaches to develop mechanistic disease models.

More information can be found on the LCSB website.

The Digital Medicine Group


The Digital Medicine group headed by the newly recruited FNR-PEARL Chair Prof. Dr. med. Jochen Klucken, focuses on shaping and innovating personalised digital healthcare solutions, and understanding and evaluating the new benchmarks of a new ecosystem for digital medicine. With a highly interdisciplinary team, the digital medicine group will address the questions of medical benefit, structural and procedural changes, as well as social acceptance of the resulting digital healthcare services. We want to understand how patient-centred, personalised healthcare technologies can be tailored to patients needs and integrated into the existing healthcare structures and procedures. We believe that shaping the rising age of digitalisation in medicine requires the development of new evaluation methods and benchmarking concepts to decipher “nice tools” from beneficial digital healthcare solutions. The aim is to enable digital medicine for patients and caregivers, innovative healthcare providers and payers.

The Digital Medicine group started in March 2021 and is supported by the FNR-PEARL Programme at the LCSB (Luxembourg Center for Systems Biomedicine) at the University of Luxembourg, the LIH (Luxembourg Institute of Health) and the dMed Research Clinic at the CHL (Centre Hospitalier de Luxembourg). To learn more about the Digital Medicine group, please visit their website.

Dr. Jochen Klucken is currently the newly appointed FNR-Pearl Chair Digital Medicine at the University of Luxembourg (LCSB), Luxembourg Institute of Health (LIH) and Centre Hospitalier de Luxembourg CHL. His medical background includes a graduate in medicine from University of Regensburg (1996), postdoctoral fellow at the Massachusetts Institute for Neurodegenerative Diseases, Harvard Medical School, USA on neurodegenerative processes in Parkinson’s disease (2002-2005), a board certification in neurology (2007) and a habilitation thesis at the University Regensburg (2009).

He has extensive interdisciplinary training during the last 25 years beyond clinical understanding of patient care and value ranging from laboratory medicine, molecular biology, cell metabolism, molecular pathology and experimental biomedicine, to medical engineering, data science and wearable sensor technologies providing better outcomes in medicine. His work strongly focuses on patient centred devices for sensor-based gait analysis systems in in Parkinson’s disease, multiple sclerosis, osteoarthritis, sarcopenia, oncology and healthy well-being of the elderly. His interdisciplinary research interest is to understand how new healthcare services and outcome parameters – “medical information” can be integrated into everyday healthcare and individualized to the patient`s need. This includes the scientific evaluation of the medical benefit of innovative healthcare technologies, but also the societal acceptance, patient participation and procedural/structural changes in digital medicine.

Scientific Committee


Prof. Jochen Klucken, FNR-PEARL Chair (UL/LCSB, LIH, CHL), Head of Digital Medicine Group

Prof. Magda Rosenmöller, Senior Lecturer & Academic Director IESE CRHIM, IESE Business School, Spain 

Menno Kok, Managing Director, Managing Director EIT Health Belgium-Netherlands

Julia Hagen Director Regulatory & Politics, Health Innovation Hub of the Federal Ministry of Health (BMG)